CG
CRL icon

Caprock Group’s Charles River Laboratories CRL Stock Holding History

Caprock Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.64M Sell
7,243
-1,357
-16% -$242K 0.03% 463
2026
Q1 		$1.48M Sell
8,600
-2,410
-22% -$447K 0.04% 436
2025
Q4 		$2.2M Sell
11,010
-353
-3% -$64K 0.05% 350
2025
Q3 		$1.86M Buy
+11,363
New +$1.8M 0.05% 368
2025
Q1 		$776K Buy
+5,158
New +$865K 0.02% 549
2022
Q4 		– Sell
-1,120
Closed -$220K – 569
2022
Q3 		$220K Sell
1,120
-161
-13% -$34.8K 0.02% 494
2022
Q2 		$274K Buy
+1,281
New +$313K 0.03% 409
2021
Q4 		– Sell
-1,060
Closed -$437K – 589
2021
Q3 		$437K Buy
1,060
+152
+17% +$63.1K 0.04% 290
2021
Q2 		$336K Buy
908
+14
+2% +$4.67K 0.03% 334
2021
Q1 		$259K Buy
894
+42
+5% +$11.7K 0.03% 383
2020
Q4 		$213K Buy
+852
New +$203K 0.02% 428
2020
Q1 		– Sell
-1,442
Closed -$220K – 374
2019
Q4 		$220K Sell
1,442
-332
-19% -$46K 0.04% 311
2019
Q3 		$235K Hold
1,774
– – 0.05% 284
2019
Q2 		$252K Hold
1,774
– – 0.05% 261
2019
Q1 		$258K Sell
1,774
-45
-2% -$5.91K 0.05% 287
2018
Q4 		$206K Hold
1,819
– – 0.05% 313
2018
Q3 		$245K Hold
1,819
– – 0.05% 315
2018
Q2 		$204K Sell
1,819
-160
-8% -$17.3K 0.04% 392
2018
Q1 		$211K Hold
1,979
– – 0.05% 382
2017
Q4 		$208K Sell
1,979
-1,470
-43% -$160K 0.04% 417
2017
Q3 		$373K Buy
+3,449
New +$354K 0.08% 236

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Caprock Group's CRL Position: Q2 2026 in Review

Caprock Group reduced its Charles River Laboratories (CRL) stake by 16% in Q2 2026, selling an estimated $242K and leaving 7,243 shares worth $1.64M. The position accounts for 0.03% of the portfolio, ranked #463.

Caprock Group first reported a position in CRL in Q3 2017 and has held it in 21 quarters since. The position peaked at $2.2M in Q4 2025. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Caprock Group held 7,243 shares of Charles River Laboratories worth $1.64M as of Q2 2026.
  • Caprock Group sold 1,357 Charles River Laboratories shares in Q2 2026, an estimated $242K.
  • Charles River Laboratories made up 0.03% of Caprock Group's portfolio in Q2 2026, its #463 holding.
  • Caprock Group first reported a position in Charles River Laboratories in Q3 2017 and has held it in 21 quarters since.
  • Caprock Group's Charles River Laboratories position peaked at $2.2M in Q4 2025.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.